Concepedia

Author

Nikolai Siebert

Universitätsmedizin GreifswaldORCID

Also Known As

N Siebert, N. Siebert, Nikolai Siebert, Nikolai Siebert (630387)

97

Publications

1.2K

Citations

19

H-Index

59

Concepts

All Affiliations

Universitätsmedizin GreifswaldUniversity of RostockSt Anna Children's HospitalInstitut Gustave RoussyApeiron Biologics (Austria)
NS

About

Nikolai Siebert is an author at Universitätsmedizin Greifswald specializing in immunology, immunotherapy, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

15

394

2

Cell Biology

6

6

216

3

Health Sciences

1

1

20

4

Allergy

1

1

41

5

Cellular Therapies

1

1

14

Nikolai Siebert

×

31

Publications

1.1K

Citations

19

H-Index

YearCitations

EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells

Sareetha Kailayangiri, Bianca Altvater, Stefanie Lesch,

Molecular Therapy

2019

123

H<sub>2</sub>S contributes to the hepatic arterial buffer response and mediates vasorelaxation of the hepatic artery via activation of K<sub>ATP</sub> channels

Nikolai Siebert, Daniel Cantré, Christian Eipel,

American Journal of Physiology-Gastrointestinal and Liver Physiology

2008

69

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO

Ina Mueller, Karoline Ehlert, Stefanie Endres,

mAbs

2017

67

PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD<sub>2</sub> antibody ch14.18/CHO

Nikolai Siebert, Maxi Zumpe, Madlen Jüttner,

OncoImmunology

2017

63

GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18

Wolfgang Glienke, Anna Christina Dragon, Katharina Zimmermann,

Frontiers in Immunology

2022

62

Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis

Gábor Erős, Saleh Ibrahim, Nikolai Siebert,

Arthritis Research & Therapy

2009

59

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2

Nikolai Siebert, Christin Eger, Diana Seidel,

mAbs

2016

56

Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and improved event-free survival

Nikolai Siebert, Christian Fuglesang S. Jensen, Sascha Troschke‐Meurer,

OncoImmunology

2016

55

Erythropoietin improves skin wound healing and activates the TGF-β signaling pathway

Nikolai Siebert, Weiguo Xu, Eberhard Grambow,

Laboratory Investigation

2011

53

Vaccination with anti-idiotype antibody ganglidiomab mediates a GD2-specific anti-neuroblastoma immune response

Holger N. Lode, Manuela Schmidt, Diana Seidel,

Cancer Immunology Immunotherapy

2013

50

Page 1